|
US5939401A
(en)
*
|
1994-12-09 |
1999-08-17 |
Genzyme Corporation |
Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
|
|
US6383814B1
(en)
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
|
US6331524B1
(en)
|
1994-12-09 |
2001-12-18 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
|
|
US5948767A
(en)
*
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
|
AU6011496A
(en)
*
|
1995-06-08 |
1997-01-09 |
Therexsys Limited |
Improved pharmaceutical compositions for gene therapy
|
|
FR2741066B1
(fr)
|
1995-11-14 |
1997-12-12 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
|
FR2756491B1
(fr)
*
|
1996-11-29 |
1999-01-08 |
Rhone Poulenc Rorer Sa |
Composition transfectante utile en therapie genique associan t a un virus recombinant incorporant un acide nucleique exog ene, un agent de transfection non viral et non plasmidique
|
|
FR2750704B1
(fr)
|
1996-07-04 |
1998-09-25 |
Rhone Poulenc Rorer Sa |
Procede de production d'adn therapeutique
|
|
CN1181422A
(zh)
*
|
1996-10-31 |
1998-05-13 |
上海市肿瘤研究所 |
与生长因子受体结合的多肽所构建的基因转移载体
|
|
US7008776B1
(en)
|
1996-12-06 |
2006-03-07 |
Aventis Pharmaceuticals Inc. |
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
|
|
WO1998024888A2
(en)
|
1996-12-06 |
1998-06-11 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Polypeptides encoded by a human lipase-like gene, compositions and methods
|
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
|
KR20010020342A
(ko)
|
1997-04-28 |
2001-03-15 |
자끄 사비나 |
종양치료용 맥관형성 길항제의 아데노바이러스-매개 종양내 전달방법
|
|
FR2763943B1
(fr)
*
|
1997-05-28 |
1999-07-09 |
Rhone Poulenc Rorer Sa |
Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
|
|
US6875606B1
(en)
|
1997-10-23 |
2005-04-05 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Human α-7 nicotinic receptor promoter
|
|
FR2774394B1
(fr)
*
|
1998-01-30 |
2002-04-26 |
Rhone Poulenc Rorer Sa |
Composes transfectants sensibles aux conditions reductrices, compositions pharmaceutiques les contenant, et leurs applications
|
|
EP1049793B1
(fr)
|
1998-01-30 |
2005-10-12 |
Aventis Pharma S.A. |
Composes transfectants sensibles aux conditions reductrices, compositions pharmaceutiques les contenant, et leurs applications
|
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
|
AU772033B2
(en)
*
|
1998-12-03 |
2004-04-08 |
Aventis Pharma S.A. |
Novel nucleic acid transferring agents, compositions containing them and uses
|
|
FR2786700B1
(fr)
*
|
1998-12-03 |
2002-12-06 |
Aventis Pharma Sa |
Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
|
|
US6441156B1
(en)
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
|
EP1154756B1
(en)
*
|
1999-02-22 |
2007-01-03 |
Georgetown University |
Antibody fragment-targeted immunoliposomes for systemic gene delivery
|
|
US9034329B2
(en)
*
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
US7780882B2
(en)
*
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
GB9918670D0
(en)
|
1999-08-06 |
1999-10-13 |
Celltech Therapeutics Ltd |
Biological product
|
|
ES2238799T3
(es)
*
|
1999-09-09 |
2005-09-01 |
Curevac Gmbh |
Transferencia de arn-m.
|
|
WO2001023537A1
(en)
*
|
1999-09-24 |
2001-04-05 |
Cyto Pulse Sciences, Inc. |
Process for enhancing electric field-mediated delivery of biological materials into cells
|
|
ES2368419T3
(es)
|
2000-03-13 |
2011-11-17 |
Cornell Research Foundation, Inc. |
Bloqueo de la migración de leucocitos y de la inflamación por interferencia con cd99/hec2.
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
|
EP1272222A2
(en)
*
|
2000-04-12 |
2003-01-08 |
Implyx Ltd. |
Compositions for drug delivery
|
|
JP2003531149A
(ja)
|
2000-04-13 |
2003-10-21 |
ザ・ロツクフエラー・ユニバーシテイ |
抗体由来の免疫応答の増強
|
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US20040142474A1
(en)
*
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
|
FR2814370B1
(fr)
*
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
US7060442B2
(en)
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
|
US7118756B2
(en)
|
2000-12-28 |
2006-10-10 |
Wyeth |
Recombinant protective protein from Streptococcus pneumoniae
|
|
US20030125239A1
(en)
*
|
2001-02-02 |
2003-07-03 |
Andrea Crisanti |
Compositions for drug delivery
|
|
WO2002063026A1
(en)
*
|
2001-02-08 |
2002-08-15 |
Geneporter, Inc. |
Complexes and components thereof for introducing polynucleotides into eukaryotic cells
|
|
DK1373470T3
(da)
|
2001-02-20 |
2013-07-29 |
Intrexon Corp |
Hidtil ukendte substitutionsmutantreceptorer og deres anvendelse i et cellekernereceptorbaseret inducerbart genekspressionssystem
|
|
EP1572862B1
(en)
|
2001-02-20 |
2012-08-01 |
Intrexon Corporation |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
JP4994563B2
(ja)
|
2001-02-20 |
2012-08-08 |
イントレキソン コーポレーション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
|
DK1456346T3
(da)
|
2001-02-20 |
2012-05-29 |
Intrexon Corp |
Nyt inducerbart genekspressionssystem baseret på ecdysonreceptor/invertebrat-retinoid-x-receptor
|
|
WO2002070665A2
(en)
|
2001-03-02 |
2002-09-12 |
The Rockefeller University |
Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
|
|
US8216585B2
(en)
|
2001-05-25 |
2012-07-10 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
|
WO2002100435A1
(en)
*
|
2001-06-11 |
2002-12-19 |
Centre Hospitalier Universitaire De Montreal |
Compositions and methods for enhancing nucleic acid transfer into cells
|
|
FR2829136B1
(fr)
*
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
|
MXPA04002808A
(es)
|
2001-09-26 |
2005-06-06 |
Rheogene Holdings Inc |
Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos.
|
|
MXPA04002810A
(es)
|
2001-09-26 |
2005-06-06 |
Rheogene Holdings Inc |
Acidos nucleicos receptores de ecdisona de saltarilla, polipeptidos, y sus usos.
|
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
ES2635247T3
(es)
|
2002-01-17 |
2017-10-03 |
Alfa Laval Corporate Ab |
Evaporador sumergido que comprende un intercambiador de calor de placas y una carcasa cilíndrica en la que está dispuesto el intercambiador de calor de placas
|
|
US7037520B2
(en)
*
|
2002-03-22 |
2006-05-02 |
Baylor College Of Medicine |
Reversible masking of liposomal complexes for targeted delivery
|
|
US7375093B2
(en)
|
2002-07-05 |
2008-05-20 |
Intrexon Corporation |
Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
EP1545593A1
(en)
*
|
2002-09-27 |
2005-06-29 |
PowderJect Research Limited |
Nucleic acid coated particles
|
|
JP2006517790A
(ja)
*
|
2003-01-09 |
2006-08-03 |
インヴィトロジェン コーポレーション |
ポリペプチド−核酸複合体の細胞の送達および活性化
|
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US20070065409A1
(en)
*
|
2003-07-15 |
2007-03-22 |
Behrooz Sharifi |
Use of pleiotrophin in the diagnosis, treatment and prevention of disease
|
|
US8062891B2
(en)
|
2003-10-24 |
2011-11-22 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to plants
|
|
US8133733B2
(en)
|
2003-10-24 |
2012-03-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to target tissues
|
|
US20090123468A1
(en)
|
2003-10-24 |
2009-05-14 |
Gencia Corporation |
Transducible polypeptides for modifying metabolism
|
|
US20090208478A1
(en)
*
|
2003-10-24 |
2009-08-20 |
Gencia Corporation |
Transducible polypeptides for modifying metabolism
|
|
US8507277B2
(en)
|
2003-10-24 |
2013-08-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides
|
|
CA2543257C
(en)
|
2003-10-24 |
2013-12-31 |
Gencia Corporation |
Methods and compositions for delivering polynucleotides
|
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
|
EP2267458A3
(en)
|
2004-04-20 |
2011-04-06 |
Galapagos N.V. |
Methods, compositions and compound assays for inhibiting amyloid-beta protein production
|
|
EP2214018B1
(en)
|
2004-04-27 |
2013-06-26 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
EP2270160A1
(en)
|
2004-06-14 |
2011-01-05 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
|
|
JP5022217B2
(ja)
|
2004-06-18 |
2012-09-12 |
デューク ユニバーシティー |
匂い物質受容体のモジュレーター
|
|
WO2005124342A2
(en)
|
2004-06-21 |
2005-12-29 |
Galapagos N.V. |
Methods and means for treatment of osteoarthritis
|
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
|
BRPI0513390A
(pt)
|
2004-07-16 |
2008-05-06 |
Us Gov Health & Human Serv |
vacinas contra aids contendo construções de ácido nucléico cmv/r
|
|
US7485468B2
(en)
|
2004-10-15 |
2009-02-03 |
Galapagos Bv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
|
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
|
EP1912679A4
(en)
*
|
2005-06-15 |
2009-07-29 |
Massachusetts Inst Technology |
AMINOUS LIPIDS AND ITS USES
|
|
US8088382B2
(en)
|
2005-07-05 |
2012-01-03 |
Cornell Research Foundation, Inc. |
Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies
|
|
WO2007028147A2
(en)
|
2005-09-01 |
2007-03-08 |
Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin |
Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
|
|
KR20140135267A
(ko)
*
|
2006-05-15 |
2014-11-25 |
조지타운 유니버시티 |
치료제 또는 진단제의 전신 투여를 위한 항체- 또는 항체 단편-표적화 면역리포좀 제제 및 그의 용도
|
|
KR100857389B1
(ko)
|
2006-06-30 |
2008-09-11 |
(주)아모레퍼시픽 |
Ａｐ-ｇｒｒ 펩티드 또는 ａｐ-ｇｒｒ 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
|
|
AU2007276793B2
(en)
|
2006-07-28 |
2014-01-16 |
Sanofi |
Composition and method for treatment of tumors
|
|
US20100035974A1
(en)
*
|
2006-10-04 |
2010-02-11 |
Centre National De La Recherche Scientifique (Cnrs |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
EP2155910A4
(en)
|
2007-05-08 |
2010-06-02 |
Univ Duke |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND REGULATING ODOR PERCEPTION
|
|
DK2167458T3
(en)
|
2007-05-29 |
2018-06-18 |
Intrexon Corp |
CHIRAL DIACYL HYDRAZINE LIGANDS FOR MODULATING EXPRESSION OF EXOGENEOUS GENES OF AN ECDYSON RECEPTOR COMPLEX
|
|
WO2008155397A2
(en)
|
2007-06-20 |
2008-12-24 |
Galapagos N.V. |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
|
|
US20090069266A1
(en)
|
2007-06-27 |
2009-03-12 |
Northwestern University |
Methods and compositions for nucleic acid transfer into cells
|
|
CN106890142A
(zh)
*
|
2007-07-09 |
2017-06-27 |
乔治敦大学 |
关于使用阳离子脂质体介导的核酸递送产生免疫应答的方法
|
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
|
CA2698212A1
(en)
|
2007-08-23 |
2009-02-26 |
Intrexon Corporation |
Methods and compositions for diagnosing disease
|
|
CN101970012A
(zh)
*
|
2007-09-14 |
2011-02-09 |
日东电工株式会社 |
药物载体
|
|
KR20100068435A
(ko)
*
|
2007-09-17 |
2010-06-23 |
롬 앤드 하아스 컴패니 |
식물의 생리적 반응을 변형시키기 위한 조성물 및 방법
|
|
EP2042193A1
(en)
|
2007-09-28 |
2009-04-01 |
Biomay AG |
RNA Vaccines
|
|
NZ584848A
(en)
|
2007-09-28 |
2012-09-28 |
Intrexon Corp |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
|
MX2010003720A
(es)
|
2007-10-08 |
2010-10-20 |
Intrexon Corp |
Celulas dendriticas creadas por ingenieria genetica y usos para el tratamiento de cancer.
|
|
FR2928373B1
(fr)
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
|
EP2352828B1
(en)
|
2008-09-11 |
2015-02-25 |
Galapagos N.V. |
Method for identifying compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
|
|
PE20120116A1
(es)
|
2008-11-05 |
2012-02-18 |
Wyeth Llc |
Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta hemolitica (bhs)
|
|
MX353900B
(es)
|
2008-11-07 |
2018-02-01 |
Massachusetts Inst Technology |
Lipidoides de aminoalcohol y usos de los mismos.
|
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
|
EP2398480A1
(en)
|
2009-02-19 |
2011-12-28 |
Galapagos N.V. |
Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
|
|
WO2010094734A2
(en)
|
2009-02-19 |
2010-08-26 |
Biofocus Dpi B.V. |
Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
|
|
JP2012517821A
(ja)
|
2009-02-19 |
2012-08-09 |
ガラパゴス・ナムローゼ・フェンノートシャップ |
炎症を包含する疾患の診断及び治療に有用な同定方法及び化合物
|
|
US8993509B2
(en)
|
2009-03-31 |
2015-03-31 |
Robert Zimmerman |
Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity
|
|
WO2010112569A1
(en)
|
2009-03-31 |
2010-10-07 |
Robert Zimmermann |
Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
|
|
US8663930B2
(en)
|
2009-04-01 |
2014-03-04 |
Galapagos Nv |
Methods and means for treatment of osteoarthritis
|
|
CN102724993B
(zh)
|
2009-04-17 |
2016-04-27 |
纽约大学 |
靶向tnf家族受体并拮抗tnf作用的肽、组合物、方法及其用途
|
|
WO2011015572A1
(en)
|
2009-08-03 |
2011-02-10 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases
|
|
WO2011015573A1
(en)
|
2009-08-03 |
2011-02-10 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases
|
|
WO2011116351A2
(en)
|
2010-03-19 |
2011-09-22 |
University Of South Alabama |
Methods and compositions for the treatment of cancer
|
|
AU2011232435B2
(en)
|
2010-03-23 |
2016-01-28 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
MX350142B
(es)
|
2010-08-23 |
2017-08-28 |
Wyeth Llc * |
Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
|
|
SG187912A1
(en)
|
2010-09-10 |
2013-04-30 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
CA2819552C
(en)
|
2010-12-09 |
2023-09-26 |
Institut Pasteur |
Mgmt-based method for obtaining high yield of recombinant protein expression
|
|
EP2492279A1
(en)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Rapid immunogen selection method using lentiviral display
|
|
EP3450568A3
(en)
|
2011-03-04 |
2019-04-24 |
Intrexon Corporation |
Vectors conditionally expressing protein
|
|
DK2691443T3
(da)
|
2011-03-28 |
2021-05-03 |
Massachusetts Inst Technology |
Konjugerede lipomerer og anvendelser af disse
|
|
WO2012135696A2
(en)
|
2011-04-01 |
2012-10-04 |
University Of South Alabama |
Methods and compositions for the diagnosis, classification, and treatment of cancer
|
|
EP2546358A1
(en)
|
2011-07-15 |
2013-01-16 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and reagents for efficient control of HIV progression
|
|
WO2013043720A1
(en)
|
2011-09-20 |
2013-03-28 |
The University Of North Carolina At Chapel Hill |
Regulation of sodium channels by plunc proteins
|
|
WO2013053765A1
(en)
|
2011-10-11 |
2013-04-18 |
Proyecto De Biomedicina Cima, S.L. |
A non-human animal model of mucosa-associated lymphoid tissue (malt) lymphoma
|
|
NZ747501A
(en)
|
2011-10-27 |
2020-05-29 |
Massachusetts Inst Technology |
Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
|
|
ES2648899T3
(es)
|
2011-12-09 |
2018-01-08 |
Institut Pasteur |
Inmunoensayo de cribado múltiplex
|
|
WO2013103401A1
(en)
|
2012-01-06 |
2013-07-11 |
University Of South Alabama |
Methods and compositions for the treatment of cancer
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
KR101763625B1
(ko)
|
2012-03-09 |
2017-08-01 |
화이자 인코포레이티드 |
수막염균 조성물 및 이의 사용 방법
|
|
EP2698377A1
(en)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Enhanced rapid immunogen selection method for HIV gp120 variants
|
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
JP2016518812A
(ja)
|
2013-03-14 |
2016-06-30 |
ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓ Ｎ．Ｖ． |
線維症治療において有用な分子標的及び前記標的のインヒビター
|
|
EP2972322B1
(en)
|
2013-03-14 |
2019-03-06 |
Galapagos NV |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases
|
|
WO2014139885A2
(en)
|
2013-03-14 |
2014-09-18 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of diseases associated with epithelial mesenchymal transition
|
|
WO2014144380A1
(en)
|
2013-03-15 |
2014-09-18 |
Intrexon Corporation |
Boron-containing diacylhydrazines
|
|
WO2014193800A2
(en)
|
2013-05-28 |
2014-12-04 |
The Johns Hopkins University |
Aptamers for the treatment of sickle cell disease
|
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
|
CN107406373B
(zh)
|
2014-09-17 |
2020-04-28 |
英特瑞克斯顿股份有限公司 |
含硼的二酰基肼化合物
|
|
WO2016127057A1
(en)
|
2015-02-06 |
2016-08-11 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting factor viii gene expression cassettes and their use
|
|
CN107249626A
(zh)
|
2015-02-19 |
2017-10-13 |
辉瑞大药厂 |
脑膜炎奈瑟球菌组合物及其方法
|
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
|
HRP20230494T1
(hr)
|
2015-06-19 |
2023-08-04 |
Massachusetts Institute Of Technology |
Alkenil supstituirani 2,5-piperazindioni i njihova upotreba u pripravcima za isporuku sredstva subjektu ili stanici
|
|
EP3352800B1
(en)
|
2015-09-24 |
2022-01-05 |
The University of North Carolina at Chapel Hill |
Methods and compositions for reducing metastases
|
|
WO2017062953A1
(en)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
BR112018017144A2
(pt)
|
2016-02-22 |
2019-01-15 |
Univ North Carolina Chapel Hill |
inibidores de peptídeo de canais de cálcio
|
|
CN110139933B
(zh)
|
2016-11-09 |
2024-03-08 |
英特瑞克斯顿股份有限公司 |
共济蛋白表达构建体
|
|
JP6661797B2
(ja)
|
2016-11-22 |
2020-03-11 |
株式会社東芝 |
核酸凝縮ペプチド、核酸凝縮ペプチドセット、核酸送達キャリア、核酸送達方法、細胞作製方法、細胞検出方法及びキット
|
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
AU2018225180B2
(en)
|
2017-02-22 |
2024-09-12 |
Io Biosciences, Inc. |
Nucleic acid constructs comprising gene editing multi-sites and uses thereof
|
|
EP3720975A1
(en)
|
2017-12-08 |
2020-10-14 |
Centre National de la Recherche Scientifique - CNRS |
Bioluminescent screening test for detecting cell cytolysis
|
|
EP3539975A1
(en)
|
2018-03-15 |
2019-09-18 |
Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron |
Micropeptides and uses thereof
|
|
CN113366017B
(zh)
|
2018-08-10 |
2024-05-28 |
优特力克斯有限公司 |
结合hla-dr的嵌合抗原受体和car-t细胞
|
|
WO2020185628A1
(en)
|
2019-03-08 |
2020-09-17 |
Obsidian Therapeutics, Inc. |
Cd40l compositions and methods for tunable regulation
|
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
|
CA3155669A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US20230056856A1
(en)
|
2020-01-08 |
2023-02-23 |
Obsidian Therapeutics, Inc. |
Compositions and methods for tunable regulation of transcription
|
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
|
WO2022204185A1
(en)
|
2021-03-22 |
2022-09-29 |
The University Of North Carolina At Chapel Hill |
Modified peptidomimetics and methods of use
|
|
EP4539877A1
(en)
|
2022-06-17 |
2025-04-23 |
Danmarks Tekniske Universitet |
Allergy vaccines based on consensus allergens
|
|
US12534540B2
(en)
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
WO2025109139A1
(en)
|
2023-11-23 |
2025-05-30 |
Fundació Privada Institut D'investigació Oncològica De Vall Hebron |
Rodent models obtained by knock-in of the human her2 gene
|